The state of District Of Columbia currently has 4 active clinical trials seeking participants for Autism research studies. These trials are conducted in various cities, including Washington, Washington, D.C., Washington DC and Washington, Dc.
Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum Disorder
NCT05523895
Recruiting
6-week, randomized, double-blind, fixed-dose, placebo-controlled, parallel group study in children and adolescents (aged 5 to17 years) with autism spectrum disorder (ASD) with irritability, agitation, or self-injurious behaviors to study the efficacy and safety of pimavanserin
Gender:
All
Ages:
Between 5 years and 17 years
Trial Updated:
06/07/2024
Locations: Children's Research Institute, Washington, District of Columbia
Conditions: Irritability Associated With Autism Spectrum Disorder
Register for Updates
Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum Disorder
NCT05555615
Recruiting
52-week, open-label extension study of double-blind study ACP-103-069 to determine the long-term safety and tolerability of pimavanserin for the treatment of irritability associated with ASD in children and adolescents (aged 5 to 17 years). ACP-103-069 is a 6-week, randomized, double-blind, fixed-dose, placebo controlled, parallel group study of pimavanserin in children and adolescents with irritability associated with autism spectrum disorder (ASD).
Gender:
All
Ages:
Between 5 years and 18 years
Trial Updated:
06/07/2024
Locations: Children's Research Institute, Washington, District of Columbia
Conditions: Irritability Associated With Autism Spectrum Disorder
Register for Updates
ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)
NCT05081245
Recruiting
ML-004-002 is a multi-center, randomized, double-blind, parallel-group, placebo-controlled study that will enroll approximately 150 adolescent and adult subjects with ASD. The primary objective is to evaluate the efficacy of ML-004 compared with placebo in the improvement of social communication deficits in subjects with ASD.
Gender:
All
Ages:
Between 12 years and 45 years
Trial Updated:
05/28/2024
Locations: Children's National Health System - The Children's Research Institute (CRI), Washington, District of Columbia
Conditions: Autism Spectrum Disorder
Register for Updates
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
NCT05396352
Recruiting
The goal of this study is to determine the impact of neuromodulation to the cerebellum on social and executive functions in neurotypical young adults and young adults with autism.
Gender:
All
Ages:
Between 18 years and 35 years
Trial Updated:
07/18/2023
Locations: American University, Washington, District of Columbia
Conditions: Autism, Autism Spectrum Disorder
Register for Updates